Scheurer, J., Reisser, T., Leithäuser, F., Messmann, J., Holzmann, K., Debatin, K.-M., & Strauss, G. (2020). Rapamycin-based graft-versus-host disease prophylaxis increases the immunosuppressivity of myeloid-derived suppressor cells without affecting T cells and anti-tumor cytotoxicity. Clinical and Experimental Immunology, 202(3), 407-422. https://doi.org/10.1111/cei.13496 (Original work published 2020)
allogeneic bone marrow transplantation
Scheurer, J., Kitt, K., Huber, H., Fundel-Clemens, K., Pflanz, S., Debatin, K.-M., & Strauss, G. (2021). Graft-Versus-Host Disease Prevention by In Vitro-Generated Myeloid-Derived Suppressor Cells Is Exclusively Mediated by the CD11b+CD11c+ MDSC Subpopulation. Frontiers in Immunology, 12, 754316. https://doi.org/10.3389/fimmu.2021.754316 (Original work published 2021)